School of Life Sciences and Technology, Institute for Regenerative Medicine, Shanghai Key Laboratory of Signaling and Disease Research, Frontier Science Center for Stem Cell Research, School of Life Sciences and Technology, Shanghai East Hospital, Shanghai Institute of Stem Cell Research and Clinical Translation, Tongji University, 1239 Siping Road, Shanghai, 200092, China.
Institute for Regenerative Medicine, School of Life Sciences and Technology, Shanghai East Hospital, Tongji University, Shanghai, 200092, China.
Basic Res Cardiol. 2024 Feb;119(1):169-192. doi: 10.1007/s00395-023-01021-1. Epub 2023 Dec 26.
Adult mammalian cardiomyocytes have minimal cell cycle capacity, which leads to poor regeneration after cardiac injury such as myocardial infarction. Many positive regulators of cardiomyocyte cell cycle and cardioprotective signals have been identified, but extracellular signals that suppress cardiomyocyte proliferation are poorly understood. We profiled receptors enriched in postnatal cardiomyocytes, and found that very-low-density-lipoprotein receptor (Vldlr) inhibits neonatal cardiomyocyte cell cycle. Paradoxically, Reelin, the well-known Vldlr ligand, expressed in cardiac Schwann cells and lymphatic endothelial cells, promotes neonatal cardiomyocyte proliferation. Thrombospondin1 (TSP-1), another ligand of Vldlr highly expressed in adult heart, was then found to inhibit cardiomyocyte proliferation through Vldlr, and may contribute to Vldlr's overall repression on proliferation. Mechanistically, Rac1 and subsequent Yap phosphorylation and nucleus translocation mediate the regulation of the cardiomyocyte cell cycle by TSP-1/Reelin-Vldlr signaling. Importantly, Reln mutant neonatal mice displayed impaired cardiomyocyte proliferation and cardiac regeneration after apical resection, while cardiac-specific Thbs1 deletion and cardiomyocyte-specific Vldlr deletion promote cardiomyocyte proliferation and are cardioprotective after myocardial infarction. Our results identified a novel role of Vldlr in consolidating extracellular signals to regulate cardiomyocyte cell cycle activity and survival, and the overall suppressive TSP-1-Vldlr signal may contribute to the poor cardiac repair capacity of adult mammals.
成年哺乳动物心肌细胞的细胞周期能力有限,这导致心肌损伤(如心肌梗死)后再生能力较差。已经鉴定出许多心肌细胞细胞周期和心脏保护信号的正向调节因子,但对抑制心肌细胞增殖的细胞外信号知之甚少。我们对富含于出生后心肌细胞中的受体进行了分析,发现极低密度脂蛋白受体(Vldlr)抑制新生鼠心肌细胞的细胞周期。矛盾的是,Reelin 是心脏施万细胞和淋巴管内皮细胞中表达的已知 Vldlr 配体,可促进新生鼠心肌细胞增殖。然后发现,Vldlr 的另一种配体,在成年心脏中高度表达的血小板反应蛋白 1(TSP-1),通过 Vldlr 抑制心肌细胞增殖,并且可能有助于 Vldlr 对增殖的整体抑制。在机制上,Rac1 和随后的 Yap 磷酸化和核易位介导了 TSP-1/Reelin-Vldlr 信号对心肌细胞细胞周期的调节。重要的是,Reln 突变的新生鼠在顶端切除后表现出心肌细胞增殖受损和心脏再生能力下降,而心脏特异性 Thbs1 缺失和心肌细胞特异性 Vldlr 缺失促进心肌细胞增殖,并在心肌梗死后具有心脏保护作用。我们的研究结果确定了 Vldlr 在整合细胞外信号以调节心肌细胞细胞周期活性和存活中的新作用,并且总体抑制性的 TSP-1-Vldlr 信号可能有助于成年哺乳动物心脏修复能力差。